A polymorphism of HMGA1 is associated with increased risk of metabolic syndrome and related components

Scientific Reports

Volumn 3, Issue , 2013, Pages

  Chiefari, Eusebio ^a   Tanyolaç, Sinan ^b   Iiritano, Stefania ^a   Sciacqua, Angela ^a   Capula, Carmelo ^c   Arcidiacono, Biagio ^a   Nocera, Aurora ^a   Possidente, Katiuscia ^a   Baudi, Francesco ^a   Ventura, Valeria ^a   Brunetti, Giuseppe ^d   Brunetti, Francesco S ^a   Vero, Raffaella ^c   Maio, Raffaele ^a   Greco, Manfredi ^a   Pavia, Maria ^a   Hodoglugil, Ugur ^e   Durlach, Vincent ^f   Pullinger, Clive R ^g   Goldfine, Ira D ^h   Perticone, Francesco ^a   Foti, Daniela ^a   Brunetti, Antonio ^a   more..

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b AMERICAN HOSPITAL   (Turkey)

^c PUGLIESE CIACCIO HOSPITAL   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

^e GLADSTONE INSTITUTE OF CARDIOVASCULAR DISEASE   (United States)

^f SERVICE DE DERMATOLOGIE   (France)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH MOBILITY GROUP A1A PROTEIN;

CASE CONTROL STUDY; DEMOGRAPHY; FEMALE; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETICS; HUMAN; INSULIN RESISTANCE; ITALY; MALE; METABOLIC SYNDROME X; MIDDLE AGED; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; TURKEY; ARTICLE; GENETIC ASSOCIATION; TURKEY (REPUBLIC);

CASE-CONTROL STUDIES; DEMOGRAPHY; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HMGA1A PROTEIN; HUMANS; INSULIN RESISTANCE; ITALY; MALE; METABOLIC SYNDROME X; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; TURKEY;

EID: 84875795546     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep01491     Document Type: Article

References (49)

1. Lorenzo, C., Williams, K., Hunt, K. J. & Haffner, S. M. The National Cholesterol Education Program-Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes. Diabetes Care 30, 8-13 (2007).
2. Cornier, M. A. et al. The metabolic syndrome. Endocr. Rev. 29, 777-822 (2008).
3. Erickson, S. K. Nonalcoholic fatty liver disease. J. Lipid Res. 50 Suppl, S412-416 (2009).
4. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment ofHigh Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106, 3143-3421 (2002).
5. Alberti, K. G. et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120, 1640-1645 (2009).
6. Gallagher, E. J., Leroith, D. & Karnieli, E. The metabolic syndrome-from insulin resistance to obesity and diabetes. Med. Clin. North Am. 95, 855-873 (2011).
7. Reaven, G. M. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37, 1595-1607 (1988). (Pubitemid 19004941)
8. Haas, J. T. & Biddinger, S. B. Dissecting the role of insulin resistance in the metabolic syndrome. Curr. Opin. Lipidol. 20, 206-120 (2009).
9. Cheal, K. L. et al. Relationship to insulin resistance of the adult treatment panel III diagnostic criteria for identification of the metabolic syndrome. Diabetes 53, 1195-1200 (2004). (Pubitemid 38569003)
10. Carr, D. B. et al. Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome. Diabetes 53, 2087-2094 (2004). (Pubitemid 38970759)
11. Verhagen, S. N. et al. Insulin resistance increases the occurrence of new cardiovascular events in patients with manifest arterial disease without known diabetes. The SMART study. Cardiovasc. Diabetol. 10, 100 (2011). doi:10.1186/1475-2840-10-100.
12. Pollex, R. L. &Hegele, R. A. Genetic determinants of the metabolic syndrome. Nat Clin Pract. Cardiovasc. Med. 3, 482-489 (2006). (Pubitemid 44288461)
13. Povel, C. M., Boer, J. M. & Feskens, E. J. Shared genetic variance between the features of the metabolic syndrome: heritability studies. Mol. Genet. Metab. 104, 666-669 (2011).
14. Aizawa, Y. et al. Cardiovascular risk factors are really linked in the metabolic syndrome: this phenomenon suggests clustering rather than coincidence. Int. J. Cardiol. 109, 213-218 (2006). (Pubitemid 44389480)
15. Benyamin, B. et al. Are there common genetic and environmental factors behind the endophenotypes associated with the metabolic syndrome Diabetologia 50, 1880-1888 (2007). (Pubitemid 47222870)
16. Sjogren, M. et al. The search for putative unifying genetic factors for components of the metabolic syndrome. Diabetologia 51, 2242-2251 (2008).
17. Foti, D., Iuliano, R., Chiefari, E. & Brunetti, A. A nucleoprotein complex containing Sp1, C/EBP beta, and HMGI-Y controls human insulin receptor gene transcription. Mol. Cell. Biol. 23, 2720-2732 (2003). (Pubitemid 36403073)
18. Foti, D. et al. Lack of the architectural factorHMGA1causes insulin resistance and diabetes in humans and mice. Nat. Med. 11, 765-773 (2005). (Pubitemid 41021209)
19. Chiefari, E. et al. Pseudogene-mediated posttranscriptional silencing of HMGA1 can result in insulin resistance and type 2 diabetes. Nat. Commun. 1, 40 (2010). doi:10.1038/ncomms1040.
20. Chiefari, E. et al. Functional variants of the HMGA1 gene and type 2 diabetes mellitus. JAMA 305, 903-912 (2011).
21. Liu, L. et al. Polymorphism of HMGA1 is associated with increased risk of type 2 diabetes among Chinese individuals. Diabetologia 55, 1685-1688 (2012).
22. Bustin, M. & Reeves, R. High-mobility-group chromosomal proteins: architectural components that facilitate chromatin function. Prog. Nucleic Acid Res. Mol. Biol. 54, 35-100 (1996).
23. Brunetti, A.,Manfioletti, G., Chiefari, E., Goldfine, I. D. & Foti, D. Transcriptional regulation of human insulin receptor gene by the high-mobility group protein HMGI(Y). FASEB J. 15, 492-500 (2001). (Pubitemid 32141441)
24. Chiefari, E. et al. HMGA1 is a novel downstream nuclear target of the insulin receptor signaling pathway. Sci Rep. 2, 251 (2012).
25. Marquez, M. et al. Low-frequency variants in HMGA1 are not associated with type 2 diabetes risk. Diabetes 61, 524-530 (2012).
26. Hock, R., Furusawa, T., Ueda, T. & Bustin, M. HMG chromosomal proteins in development and disease. Trends Cell. Biol. 17, 72-79 (2007). (Pubitemid 46206113)
27. Melillo, R. M. et al. Critical role of the HMGI(Y) proteins in adipocytic cell growth and differentiation. Mol. Cell. Biol. 21, 2485-2495 (2001). (Pubitemid 32222101)
28. Fedele, M. et al. Expression of a truncated Hmga1b gene induces gigantism, lipomatosis and B-cell lymphomas in mice. Eur. J. Cancer 47, 470-478 (2011).
29. Grundy, S. M. Does a diagnosis of metabolic syndrome have value in clinical practice Clin. Nutr. 83, 1248-1251 (2006). (Pubitemid 44713050)
30. Tirosh, A. et al. Adolescent BMI trajectory and risk of diabetes versus coronary disease. N. Engl. J. Med. 364, 1315-1325 (2011).
31. Barter, P. et al. HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events. N. Engl. J. Med. 357, 1301-1310 (2007). (Pubitemid 47481452)
32. Treff, N. R., Pouchnik, D., Dement, G. A., Britt, R. L. & Reeves, R. High-mobility group A1a protein regulates Ras/ERK signaling in MCF-7 human breast cancer cells. Oncogene 23, 777-785 (2004). (Pubitemid 38241278)
33. Yeni-Komshian, H., Carantoni, M., Abbasi, F. & Reaven, G. M. Relationship between several surrogate estimates of insulin resistance and quantification of insulin-mediated glucose disposal in 490 healthy nondiabetic volunteers. Diabetes Care 23, 171-175 (2000). (Pubitemid 30071019)
34. Bowden, D. W. et al. Coincident linkage of type 2 diabetes, metabolic syndrome, and measures of cardiovascular disease in a genome scan of the diabetes heart study. Diabetes 55, 1985-1994 (2006). (Pubitemid 44509971)
35. Edwards, K. L., Hutter, C. M.,Wan, J. Y., Kim, H. & Monks, S. A. Genome-wide linkage scan for the metabolic syndrome: the GENNID study. Obesity 16, 1596-1601 (2008). (Pubitemid 351915107)
36. Goulart, A. C. et al.Association of genetic variants with themetabolic syndrome in 20,806 white women: The Women's Health Genome Study. Am. Heart J. 158, 257-262.e1 (2009).
37. Devaney, J. M. et al. AKT1 polymorphisms are associated with risk for metabolic syndrome. Hum. Genet. 129, 129-139 (2011).
38. Povell, C. M., Boer, J. M., Reiling, E. & Feskens, E. J. Genetic variants and the metabolic syndrome: a systematic review. Obes. Rev. 12, 952-967 (2011).
39. Visscher, P. M., Hill, W. G. & Wray, N. R. Heritability in the genomics era-concepts and misconceptions. Nat. Rev. Genet. 9, 255-266 (2008).
40. Bernardi, L. et al. The effects of APOE and tau gene variability on risk of frontotemporal dementia. Neurobiol. Aging. 27, 702-709 (2006).
41. Di Gaetano, C. et al. An overview of the genetic structure within the Italian population from genome-wide data. PLoS One 7, e43759 (2012). doi:10.1371/journal.pone.0043759.
42. Hodoglugil, U. & Mahley, R. W. Turkish population structure and genetic ancestry reveal relatedness among Eurasian populations. Ann. Hum. Genet. 76, 128-141 (2012).
43. Schlueter, C., Hauke, S., Loeschke, S., Wenk, H. H. & Bullerdiek, J. HMGA1 proteins in human atherosclerotic plaques. Pathol. Res. Pract. 201, 101-107 (2005). (Pubitemid 40443823)
44. Kahn, R., Buse, J., Ferrannini, E. & Stern, M. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 28, 2289-2304 (2005). (Pubitemid 41242486)
45. Alberti, K. G., Zimmet, P., Shaw, J.&the IDF Epidemiology Task Force Consensus Group. The metabolic syndrome-a new worldwide definition. Lancet 366, 1059-1062 (2005).
46. Reaven, G. M. The metabolic syndrome: time to get off the merry-go-round J. Intern. Med. 269, 127-136 (2011).
47. Grundy, S. M. Pre-diabetes, metabolic syndrome, and cardiovascular risk. J. Am. Coll. Cardiol. 59, 635-643 (2012).
48. Povel, C. M. et al. Metabolic syndrome model definitions predicting type 2 diabetes and cardiovascular disease. Diabetes Care 36, 362-368 (2013).
49. Tanyolaç, S., Mahley, R. W.,Hodoglugil, U.&Goldfine, I. D. Gender differences in the relationship of ENPP1/PC-1 variants to obesity in a Turkish population. Obesity (Silver Spring) 16, 2468-2471 (2008).